studi
attempt
understand
fulli
host
respons
pathogenesi
associ
sever
acut
respiratori
syndrom
sar
coronaviru
sarscov
monitor
gene
express
use
formalinfix
paraffinembed
ffpe
pulmonari
autopsi
tissu
tissu
patient
differ
hospit
singapor
diagnos
variou
microbi
infect
includ
sarscov
caus
acut
respiratori
distress
syndrom
ard
global
express
pattern
show
limit
correl
endstag
ard
initi
pathogen
focus
subset
gene
implic
pulmonari
pathogenesi
molecular
signatur
pulmonari
diseas
obtain
appear
influenc
preexist
pulmonari
complic
also
bacteri
compon
infect
mani
factor
detect
pulmonari
damag
repair
extracellular
matrix
ecm
compon
transform
growth
factor
tgf
enhanc
acutephas
protein
antioxid
includ
molecular
profil
ard
lung
tissu
addit
differenti
express
cytokin
within
pulmonari
tissu
observ
includ
notabl
gene
involv
interferon
ifn
pathway
ifn
regulatori
often
character
elev
ard
patient
clinic
cours
sever
acut
respiratori
syndrom
coronaviru
sarscov
infect
variabl
fatal
case
progress
acut
respiratori
distress
syndrom
ard
predomin
patholog
diffus
alveolar
damag
dad
sar
captur
attent
world
new
diseas
suggest
clinic
term
sar
variant
ard
attribut
sarscov
sarscov
produc
uniqu
cytopath
chang
although
suspici
direct
viral
effect
chang
seen
formalinfix
paraffinembed
ffpe
tissu
within
spectrum
seen
endstag
ardsdad
case
initi
variou
pathogen
present
studi
attempt
provid
insight
host
respons
ensu
pathogenesi
associ
sarscov
use
ffpe
pulmonari
autopsi
tissu
singapor
patient
diagnos
assort
microbi
infect
includ
sarscov
necessarili
limit
sampl
size
studi
chose
focu
effort
subset
gene
whose
role
implic
clinic
ard
experiment
pulmonari
stress
studi
rather
tri
use
microarray
analysi
hypothesisgener
discoveri
tool
although
feasibl
host
respons
pulmonari
infect
could
trace
origin
etiolog
agent
current
clinic
techniqu
alway
establish
correl
therefor
sought
determin
molecular
signatur
ard
lung
diseas
possibl
distinguish
ard
case
initi
sarscov
autopsi
sampl
sent
consult
arm
forc
institut
patholog
afip
tan
tock
seng
hospit
health
scienc
author
singapor
brief
overview
clinic
patholog
featur
ffpe
lung
tissu
shown
tabl
previous
report
rna
extract
ffpe
tissu
afip
previous
describ
total
rna
isol
doubl
amplifi
use
riboamp
rna
amplif
kit
arcturu
mountain
view
ca
qualiti
rna
evalu
use
agil
bioanalyz
agil
technolog
palo
alto
ca
microarray
format
protocol
describ
websit
expressionmicrosluwashingtonedu
experiment
design
microarray
analys
involv
experiment
sampl
cohybrid
refer
sampl
human
cdna
array
uniqu
cdna
clone
experiment
sampl
individu
patient
sampl
repres
variou
ard
case
refer
sampl
creat
pool
equal
quantiti
amplifi
rna
pulmonari
experiment
sampl
singl
microarray
experi
incorpor
revers
dyelabel
techniqu
result
four
measur
gene
allow
calcul
mean
ratio
among
express
level
standard
deviat
sd
p
valu
within
rosetta
resolv
system
rosetta
biosoftwar
seattl
wa
gene
select
differenti
express
base
two
criteria
p
fold
chang
furthermor
paramet
need
hold
true
two
five
experi
two
select
believ
would
allow
similar
two
sarsposit
case
similar
two
preexist
pulmonari
complic
asthma
congest
heart
failur
chf
studi
two
oneway
analys
varianc
anova
perform
first
anova
analysi
ard
initi
sarscov
defin
one
popul
ard
initi
pathogen
defin
anoth
popul
altern
anova
analysi
ard
preexist
pulmonari
complic
defin
one
popul
ard
without
preexist
pulmonari
complic
defin
anoth
popul
stringent
anova
p
valu
cutoff
use
select
gene
best
discern
two
group
data
normal
error
model
calcul
slide
format
describ
expressionmicrosluwashingtonedu
websit
also
use
publish
primari
data
accord
propos
standard
bioset
made
mine
protein
loung
pathway
wwwproteinloungecom
combin
gene
interest
variou
literatur
sourc
although
feasibl
system
host
respons
pulmonari
infect
could
trace
origin
etiolog
agent
current
clinic
techniqu
biolog
assay
alway
establish
correl
especi
later
cours
infect
endstag
ardsdad
result
final
common
pathway
lung
injuri
therefor
transcript
profil
pulmonari
tissu
use
determin
signatur
lung
diseas
progress
whether
sarscovinduc
ard
could
distinguish
ard
case
ffpe
tissu
amen
preserv
diagnost
qualiti
yet
fixat
process
previous
limit
use
molecular
biolog
applic
modif
rna
formalin
although
fix
tissu
consid
optim
obtain
pristin
rna
method
avail
recoveri
amplifi
rna
sourc
character
extract
total
rna
process
amplifi
rna
pulmonari
clinic
sampl
well
compar
control
tissu
sourc
nonhuman
primat
data
shown
show
rang
total
rna
fragment
size
bp
similar
averag
amplifi
rna
fragment
size
bp
suggest
suffici
concentr
intact
total
rna
present
attempt
gene
express
studi
fig
control
order
investig
variabl
gene
express
due
chemic
process
direct
microarray
comparison
perform
use
ffpe
tissu
obtain
one
nonhuman
primat
experiment
sampl
match
fresh
tissu
obtain
nonhuman
primat
refer
sampl
note
match
tissu
came
pulmonari
sampl
halv
fix
two
differ
manner
portion
place
rnalat
fresh
portion
place
formalin
fix
formalin
tissu
paraffin
embed
use
standard
techniqu
idea
direct
microarray
comparison
ground
idea
mrna
popul
gene
express
ident
tissu
sampl
regardless
tissu
fixat
method
use
zero
gene
would
detect
microarray
would
identifi
differenti
express
contrarili
gene
would
identifi
differenti
express
microarray
could
defin
variabl
tissu
sampl
due
tissu
fixat
method
chemic
modifi
rna
tissu
slice
posit
origin
stock
tissu
sampl
direct
microarray
comparison
match
primat
ffpe
tissu
fresh
tissu
show
gene
differenti
express
fig
demonstr
even
though
variabl
transcript
profil
elucid
tissu
undergon
extens
chemic
process
inform
gain
ffpe
tissu
concur
obtain
fresh
tissu
refer
direct
microarray
comparison
adjac
slice
ffpe
tissu
well
comparison
adjac
slice
fresh
tissu
show
gene
differenti
express
indic
gene
express
character
tissu
realli
defin
subsequ
microarray
analys
clinic
sampl
direct
comparison
experiment
sampl
refer
sampl
show
ard
experiment
sampl
exhibit
similar
number
differenti
express
gene
suggest
manner
ard
lung
tissu
chemic
process
could
consid
grossli
similar
one
anoth
color
plate
experiment
design
would
thu
highlight
differ
pathogenesi
among
variou
infecti
agent
host
respons
stratifi
diseas
state
rather
differ
diseas
health
allevi
concern
use
autopsi
sampl
endstag
diseas
would
focu
attribut
autopsi
tissu
addit
although
refer
sourc
nonard
donor
would
convent
allow
us
investig
aspect
host
respons
ard
use
pool
ard
refer
allow
us
investig
whether
pathogenspecif
host
respons
could
elucid
specif
uniqu
molecular
signatur
sarsinduc
ard
microarray
data
plot
heat
map
grid
color
point
matrix
entri
repres
gene
express
valu
red
correspond
high
express
green
correspond
low
express
black
correspond
intermedi
level
express
hierarch
cluster
method
use
order
row
gene
column
sampl
allow
one
identifi
group
sampl
similar
express
level
pattern
gene
similar
across
sampl
global
analysi
show
cluster
togeth
color
plate
adenoviru
detect
sarscov
mucor
sp
aspergillu
sp
detect
cluster
due
initi
infecti
agent
curious
howev
note
test
posit
bacteri
infect
suggest
potenti
gene
express
pattern
associ
infect
contain
bacteri
compon
sampl
set
contain
multipl
etiolog
relat
ard
singl
specimen
etiolog
combin
chose
focu
effort
subset
gene
whose
role
implic
clinic
ard
experiment
pulmonari
stress
studi
rather
tri
use
microarray
analysi
hypothesisgener
discoveri
tool
first
focus
cytokin
cytokin
dysregul
correl
hyperinflammatori
respons
diseas
sever
express
data
use
gener
color
plate
filter
use
interferon
ifn
cytokin
bioset
heat
map
gener
use
subset
gene
determin
similar
analyz
express
pattern
associ
cytokin
signal
lung
tissu
show
similar
transcript
pattern
within
notabl
gene
includ
ifn
pathway
ifn
regulatori
color
plate
shown
increas
gene
express
show
decreas
gene
express
ard
show
increas
regul
show
slight
trend
increas
regul
decreas
level
express
also
demonstr
wherea
show
increas
level
express
although
show
slight
trend
decreas
regul
irf
regul
still
consid
similar
ard
proinflammatori
cytokin
well
activ
factor
atf
observ
elev
plasma
sar
patient
well
previous
describ
ard
patient
increas
level
express
observ
decreas
level
observ
ard
case
wherea
previou
studi
focus
detect
cytokin
plasma
interest
note
patient
preexist
pulmonari
complic
asthma
chf
show
trend
transcript
level
lung
tissu
anoth
hallmark
proinflammatori
cytokin
fibrot
mediat
suppress
group
elev
somewhat
elev
two
anova
analys
next
perform
group
defin
either
ard
initi
sarscov
ard
initi
pathogen
attempt
teas
gene
attribut
direct
sarscov
effect
ard
preexist
pulmonari
complic
ard
without
preexist
pulmonari
complic
attempt
defin
gene
express
affect
underli
condit
use
analys
mani
cytokin
make
heat
map
color
plate
could
also
defin
gene
discern
preexist
pulmonari
condit
asthma
chf
indic
blue
bar
suggest
gene
express
cytokin
affect
preexist
pulmonari
condit
asthma
chf
respiratori
infect
although
anova
use
attempt
classifi
set
gene
attribut
direct
sar
effect
none
shown
enough
similar
singl
gene
differenti
express
pulmonari
damag
repair
reportedli
indic
prognosi
transcript
pattern
lung
tissu
show
similar
molecular
profil
color
plate
anova
analys
perform
describ
use
analys
mani
gene
make
pulmonari
damag
repair
heat
map
color
plate
could
also
defin
gene
discern
preexist
pulmonari
condit
indic
blue
bar
demonstr
gene
express
affect
preexist
pulmonari
condit
asthma
chf
respiratori
infect
higher
level
extracellular
matrix
ecm
compon
induc
lung
injuri
fibrosi
collagen
fibrillin
keratin
observ
enzym
respons
remodel
matric
shown
variabl
includ
plasminogen
activ
plau
respons
fibrin
bind
degrad
ecm
matrix
gelatinas
collagenas
integrin
fibronectin
receptor
respons
fixat
cell
ecm
associ
activ
transform
growth
factor
tgf
shown
differenti
regul
includ
downregul
well
addit
gene
relat
pulmonari
stress
induc
includ
acutephas
protein
airway
inflamm
antioxid
studi
date
investig
compon
pulmonari
matrix
remodel
survey
bronchial
lavag
bal
fluid
detect
solubl
mediat
interest
compar
contrast
result
use
lung
tissu
clinic
ard
patient
key
event
take
place
site
matrix
remodel
may
necessarili
reflect
solubl
marker
bal
fluid
result
lung
tissu
prove
relev
addit
gene
make
pulmonari
damag
repair
heat
map
color
plate
select
gene
discern
sar
effect
indic
yellow
bar
promin
selectin
p
ligand
selplg
observ
decreas
gene
express
compar
ard
sampl
illustr
color
plate
selplg
tend
discern
two
anova
group
sar
wherea
phospholipas
group
iia
immunoglobulin
kappa
constant
igkc
immunoglobulin
lambda
constant
insulinlik
growth
factor
receptor
appear
exclus
one
group
due
natur
anova
analysi
repres
gene
follow
larger
sampl
size
better
understand
segreg
bias
select
criteria
uniqu
marker
lung
damag
repair
potenti
caus
direct
sarscov
effect
could
consid
howev
overal
sar
resembl
ard
collect
studi
show
feasibl
use
ffpe
sampl
obtain
transcript
profil
microarray
molecular
signatur
obtain
pulmonari
autopsi
ffpe
tissu
sampl
correl
current
known
studi
solubl
protein
marker
either
bal
fluid
sera
sampl
ard
sar
patient
even
though
clinic
sampl
studi
would
contribut
increas
statist
signific
small
studi
unpreced
recur
cluster
hint
pathogenesi
may
potenti
influenc
preexist
pulmonari
complic
although
neither
asthma
chf
contribut
directli
dad
diseas
associ
pulmonari
compon
could
consid
factor
subsequ
infecti
challeng
ensu
pathogenesi
parallel
previou
suggest
patient
outcom
relat
magnitud
durat
host
inflammatori
respons
independ
precipit
caus
ard
anoth
point
interest
rapid
diseas
progress
day
show
number
strongli
upregul
cytokin
signal
gene
result
suggest
tissu
investig
earlier
diseas
progress
gene
express
might
reveal
insight
pathogenesi
base
origin
pulmonari
insult
similar
find
earli
death
day
relat
condit
precipit
ard
addit
sampl
contain
variou
pathogen
yet
bacteri
compon
infect
although
outsid
scope
discuss
attempt
detail
host
respons
individu
pathogen
compon
use
microarray
hypothesisgener
discoveri
tool
consid
sampl
size
believ
sampl
ad
creat
respiratori
pathogen
compendium
comprehens
view
ard
progress
genet
level
would
abl
supersed
current
character
ard
clinic
level
qualiti
total
rna
extract
tissu
amplifi
rna
character
use
capillari
electrophoresi
ladder
observ
six
distinct
band
size
kb
comparison
total
rna
extract
ffpe
pulmonari
autopsi
tissu
typic
fresh
sampl
b
comparison
amplifi
rna
gener
use
total
rna
gener
abund
shorter
fragment
arna
seen
shoulder
curv
arna
plot
directli
correl
use
total
rna
abund
shorter
fragment
gene
differenti
express
compar
match
ffpe
fresh
tissu
macaqu
tissu
excis
preserv
rnalat
ffpe
process
extract
total
rna
total
rna
sampl
could
amplifi
use
gener
fluoresc
label
probe
microarray
hybrid
microarray
experi
direct
comparison
ffpe
tissu
fresh
tissu
incorpor
revers
dyelabel
techniqu
result
four
measur
gene
describ
materi
method
direct
microarray
comparison
ground
idea
mrna
popul
gene
express
ident
tissu
sampl
regardless
tissu
fixat
method
use
zero
gene
would
detect
microarray
would
identifi
differenti
express
select
fold
chang
p
gene
shown
differenti
express
total
uniqu
gene
give
differenti
express
gene
signatur
gene
gene
defin
gene
upregul
gene
gene
downregul
gene
downregul
refer
gene
show
increas
gene
express
compar
refer
sampl
upregul
refer
gene
show
decreas
gene
express
compar
refer
sampl
demonstr
even
though
variabl
transcript
profil
elucid
tissu
undergon
extens
chemic
process
inform
gain
ffpe
tissu
concur
obtain
fresh
tissu
chang
p
indic
signatur
gene
differenti
express
total
number
gene
microarray
differenti
express
b
comparison
differenti
express
gene
five
separ
experi
use
hierarch
cluster
agglom
algorithm
complet
link
heurist
criteria
euclidean
distanc
metric
use
fold
chang
p
paramet
two
five
experi
discuss
materi
method
caus
agent
list
chf
repres
congest
heart
failur
gene
shown
red
upregul
gene
shown
green
downregul
individu
patient
sampl
compar
pool
refer
sampl
defin
one
popul
wherea
ard
initi
pathogen
defin
anoth
popul
altern
anova
analysi
ard
preexist
pulmonari
complic
defin
one
popul
ard
without
preexist
pulmonari
complic
defin
anoth
popul
use
scenario
factorialbas
analysi
select
gene
differ
two
group
use
criteria
gene
attribut
sar
absent
yellow
bar
number
gene
attribut
preexist
pulmonari
complic
blue
bar
